These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37367491)
1. Rapid Establishment of a Biospecimen Resource To Study the Global Impact of COVID-19 Vaccines. Berliner KE; Ezzelle T; Klenk T; Dunn G; Sischo J; Campbell D; McKee KT Microbiol Spectr; 2023 Aug; 11(4):e0211723. PubMed ID: 37367491 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children. Lima R; Gootkind EF; De la Flor D; Yockey LJ; Bordt EA; D'Avino P; Ning S; Heath K; Harding K; Zois J; Park G; Hardcastle M; Grinke KA; Grimmel S; Davidson SP; Forde PJ; Hall KE; Neilan AM; Matute JD; Lerou PH; Fasano A; Shui JE; Edlow AG; Yonker LM BMC Med Res Methodol; 2020 Sep; 20(1):228. PubMed ID: 32917141 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Biospecimen Collection During the COVID-19 Pandemic. Lankes HA; Makhlouf H Am J Clin Pathol; 2021 Jan; 155(1):55-63. PubMed ID: 32974640 [TBL] [Abstract][Full Text] [Related]
5. Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled. Shook LL; Shui JE; Boatin AA; Devane S; Croul N; Yonker LM; Matute JD; Lima RS; Schwinn M; Cvrk D; Gardner L; Azevedo R; Stanton S; Bordt EA; Yockey LJ; Fasano A; Li JZ; Yu XG; Kaimal AJ; Lerou PH; Edlow AG BMC Med Res Methodol; 2020 Aug; 20(1):215. PubMed ID: 32842979 [TBL] [Abstract][Full Text] [Related]
6. A Study of Policies and Guidelines for Collecting, Processing, and Storing Coronavirus Disease 2019 Patient Biospecimens for Biobanking and Research. Gao F; Tao L; Ma X; Lewandowski D; Shu Z Biopreserv Biobank; 2020 Dec; 18(6):511-516. PubMed ID: 33290126 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a Pediatric COVID-19 Biorepository: Unique Considerations and Opportunities for Studying the Impact of the COVID-19 Pandemic on Children. Lima R; Gootkind E; De La Flor D; Yockey L; Bordt E; D'Avino P; Ning S; Heath K; Harding K; Zois J; Park G; Hardcastle M; Grinke KA; Grimmel S; Forde PJ; Davidson SP; Hall KE; Neilan A; Matute JD; Lerou PH; Fasano A; Shui JE; Edlow AG; Yonker LM Res Sq; 2020 Sep; ():. PubMed ID: 32818214 [TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
10. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples. Sullivan PS; Sailey C; Guest JL; Guarner J; Kelley C; Siegler AJ; Valentine-Graves M; Gravens L; Del Rio C; Sanchez TH JMIR Public Health Surveill; 2020 Apr; 6(2):e19054. PubMed ID: 32310815 [TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting. Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436 [TBL] [Abstract][Full Text] [Related]
14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
15. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
18. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735 [TBL] [Abstract][Full Text] [Related]
19. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants. Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM Elife; 2022 Aug; 11():. PubMed ID: 36004719 [TBL] [Abstract][Full Text] [Related]
20. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. Angyal A; Longet S; Moore SC; Payne RP; Harding A; Tipton T; Rongkard P; Ali M; Hering LM; Meardon N; Austin J; Brown R; Skelly D; Gillson N; Dobson SL; Cross A; Sandhar G; Kilby JA; Tyerman JK; Nicols AR; Spegarova JS; Mehta H; Hornsby H; Whitham R; Conlon CP; Jeffery K; Goulder P; Frater J; Dold C; Pace M; Ogbe A; Brown H; Ansari MA; Adland E; Brown A; Chand M; Shields A; Matthews PC; Hopkins S; Hall V; James W; Rowland-Jones SL; Klenerman P; Dunachie S; Richter A; Duncan CJA; Barnes E; Carroll M; Turtle L; de Silva TI; Lancet Microbe; 2022 Jan; 3(1):e21-e31. PubMed ID: 34778853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]